English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The overall performance in the area of human health has directed its focus to patient care, taking the medicine as the background. In this sense, the human pharmacotherapeutic follow-up (which is part of the Pharmaceutical Care) has been a great tool to aid the detection of Drug Related Problems (DRP) so they can be avoided or identified in order to prevent / minimize the emergence of Drug Negative Outcomes (DNO). Considering the need of therapeutic success as a result to obtain in health care, a reflection on the possibility of a follow-up model (Dader modified) to be adapted and applied to the pharmacotherapeutic monitoring animal area, particularly, in domestic animals with chronic use of medications is presented.

SEGUIMENTO FARMACOTERAPÊUTICO DIRECIONADO AOS ANIMAIS DOMÉSTICOS: SERIA VIÁVEL?